136 related articles for article (PubMed ID: 1664423)
1. Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer.
Saxman S; Loehrer PJ; Logie K; Stephens D; Workman F; Scullin D; Einhorn LH; Ansari R
Invest New Drugs; 1991 Aug; 9(3):253-6. PubMed ID: 1664423
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study.
Einhorn LH; Pennington K; McClean J
Semin Oncol; 1990 Feb; 17(1 Suppl 2):32-5. PubMed ID: 2154857
[TBL] [Abstract][Full Text] [Related]
3. Prolonged administration of oral etoposide in non-small-cell lung cancer: a phase II trial.
Waits TM; Johnson DH; Hainsworth JD; Hande KR; Thomas M; Greco FA
J Clin Oncol; 1992 Feb; 10(2):292-6. PubMed ID: 1310104
[TBL] [Abstract][Full Text] [Related]
4. Chronic oral etoposide in non-small cell lung carcinoma.
Estapé J; Palombo H; Sánchez-Lloret J; Agustí C; Grau JJ; Daniels M; Viñolas N; Solá C; Biete A; Ramirez J
Eur J Cancer; 1992; 28A(4-5):835-7. PubMed ID: 1326308
[TBL] [Abstract][Full Text] [Related]
5. Platinum/oral etoposide therapy in non-small cell lung cancer.
Furuse K
Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.
Park J; Ahn YC; Kim H; Lee SH; Park SH; Lee KE; Lim DH; Park J; Kim K; Jung CW; Im YH; Kang WK; Lee MH; Park K
Lung Cancer; 2003 Nov; 42(2):227-35. PubMed ID: 14568691
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
8. Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
Felip E; Massuti B; Camps C; Benito D; Isla D; González-Larriba JL; López-Cabrerizo MP; Salamanca O; Puerto-Pica J; Moyano A; Baselga J; Rosell R
Clin Cancer Res; 1998 Nov; 4(11):2723-8. PubMed ID: 9829735
[TBL] [Abstract][Full Text] [Related]
9. CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.
Sandler A; Blanke C; Monaco F; Carey MA; Ansari R; Fisher B; Spiridonidis CH; Einhorn L; Nichols C
Am J Clin Oncol; 1998 Jun; 21(3):294-7. PubMed ID: 9626802
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer.
Miller AA; Tolley EA; Niell HB; Griffin JP; Mauer AM
J Clin Oncol; 1993 Jun; 11(6):1179-88. PubMed ID: 8388920
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
[TBL] [Abstract][Full Text] [Related]
12. Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancer.
Blumenreich MS; Sheth SP; Miller CL; Farnsley ES; Kellihan MJ; Joseph UG; Hamm JT; Seeger J; Robinson LH; Hagan PC
Am J Clin Oncol; 1994 Apr; 17(2):163-5. PubMed ID: 8141109
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.
Saito H; Shimokata K; Yamamoto M; Saka H; Sakai S; Saito H
Cancer Chemother Pharmacol; 1993; 32(2):134-6. PubMed ID: 8387399
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin plus oral etoposide in elderly patients with advanced non small cell lung cancer. A phase II study.
Gridelli C; Rossi A; Scognamiglio F; Guida C; Fiore F; Gatani T; Scoppa G; Pergola M
Anticancer Res; 1997; 17(6D):4755-8. PubMed ID: 9494602
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.
Lee JS; Scott C; Komaki R; Fossella FV; Dundas GS; McDonald S; Byhardt RW; Curran WJ
J Clin Oncol; 1996 Apr; 14(4):1055-64. PubMed ID: 8648357
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
18. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.
Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson G; Davis I
Lung Cancer; 2001 Apr; 32(1):89-94. PubMed ID: 11282433
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide].
Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kuno K
Gan To Kagaku Ryoho; 1994 Jan; 21(1):53-8. PubMed ID: 8291916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
